Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)
Seeking Alpha
February 18, 2026
Vertex Pharmaceuticals Incorporated faces slowing Trikafta/Kaftrio sales and a stock-price divergence with peers. Click for this VRTX earnings update.
Verticals
financemarkets
Originally published on Seeking Alpha on 2/18/2026